[Beta-adrenergic hypertonia in psychosomatic manifestations of anxiety and the therapeutic effect of a cardioselective beta-blockader: betaxolol].
Le Van
D
D
Mayeux
D
D
Kohler
C
C
Regnier
F
F
Coquelin
J P
JP
Grilliat
J P
JP
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D001007:Anxiety / Q000150:complications*; D015784:Betaxolol; D004576:Electromyography; D005260:Female; D006801:Humans; D007545:Isoproterenol; D008297:Male; D008875:Middle Aged; D009122:Muscle Hypertonia / Q000188:drug therapy* / Q000209:etiology; D009129:Muscle Tonus / Q000187:drug effects; D010919:Placebos; D011412:Propanolamines / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D010919:Placebos; D011412:Propanolamines; D007545:Isoproterenol; D015784:Betaxolol
Hypertonie bêta-adrénergique dans les manifestations psychosomatiques de l'anxiété et effet thérapeutique d'un bêta-bloquant cardio-sélectif: le bétaxolol.